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ABSTRACT
Purpose: Hepatic ischemia and reperfusion can cause several problems in hepatic surgery. The aim of this study was to
determine pyruvate kinase activation and lipid peroxidation after hepatic ischemia. Methods: Twenty-four Wistar rats were
submitted to 90 minutes of selective liver ischemia and 15 minutes of reperfusion. Twelve animals were submitted to
selective liver ischemia and reperfusion (Group A) and the other 12 were submitted to sham operation (Group B). After 15
minutes of reperfusion, the following parameters were measured: mean arterial pressure (MAP), alanine aminotransferase
(ALT), glycemia (GLY), hepatic glycogen (GH), pyruvate kinase (PK) activation, hepatic glutathione (GSH) and
malondialdehyde (MDA). Analysis of the results were made by the Student t-test and has been considered significant
difference for p<0.05. Results: A and B were differents for all parameters analized. Conclusion: The animals of group A
showed reperfusion syndrome with a fall in MAP, activation of glycid metabolism through the glycolitic pathway and
presence of lipid peroxidation compared to group B.
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RESUMO
Objetivo: A isquemia e reperfusão hepática podem causar graves repercussões hepatocelulares em cirurgias hepáticas. O
objetivo deste estudo foi determinar o comportamento da piruvato EM PORTUGUÊS quinase e a lipoperoxidação após
isquemia hepática. Métodos: Foram utilizados vinte e quatro ratos Wistar machos divididos em dois grupos. Doze animais
foram submetidos a 90 minutos de isquemia hepática seletiva e reperfusão hepática de por 15 minutos (pressão arterial
média (PAM), alanina aminotransferase (ALT), glicemia (GLI), gicogênio hepático (GH), ativação da piruvato quinase (PQ),
glutationa hepática (GSH) e malondialdeído (MDA). Os resultados foram analisados utilizando o teste t de Student sendo
as diferenças consideradas significativas para p<0,05. Resultados: Verificou-se diferença significativa entre os grupos em
todos os parâmetros analisados. Conclusão: Verificou-se que os animais do grupo A mostraram síndrome de reperfusão
com queda da PAM, ativação do metabolismo da glicose através da via glicolítica e presença de lipoperoxidação quando
comparada com o grupo B.
Descritores: Piruvato quinase. Peroxidação Lipídica. Fígado. Isquemia. Reperfusão.
Introduction
It has become increasingly apparent that the events
resulting in cellular injury during periods of tissue hypoxia
or anoxia occur primarily during reoxygenation1,2. The lack
of oxygen during ischemia reduces oxidative
phosphorylation, rapidly reducing existing cellular ATP
stores. Paradoxically, reperfusion of the organ suddenly
exposing the mitochondria to oxygen leads to the production
of oxygen-derived free radicals, which are highly reactive
molecules. It has been estimated that, under physiological
conditions, 2 to 5% of the total oxygen consumed by
mitochondria results in the formation of superoxide free
radicals (Oº) resulting in to a single electron reduction of
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oxygen in the electron transport chain. However,
mitochondria have an efficient antioxidant system
represented by the enzymes superoxide dismutase,
glutathione peroxidase, glutathione reductase, NAD(P)
trans-hydrogenase, and other compounds such as
glutathione (GSH), malondialdehyde (MDA), NADPH, and
vitamins C and E, which are fully balanced under normal
conditions. However, when free radicals are generated in
excess, this system collapses and a state of oxidative stress
is created which leads to dysfunction and permeabilization
of mitochondria as a consequence of a series of changes in
the components of the mitochondrial membrane such as
lipid peroxidation and protein-thiol oxidation1, 2. The factors
that most influence the release of these reactive species are
ischemia and subsequent reperfusion of the organ during
hepatic surgical procedures. The changes observed after
the period of ischemia/reperfusion are reflected by disorders
in microcirculation, hypotension, elevation of serum
aminotransferase and lactate dehydrogenase levels,
mitochondrial dysfunction, increased lipoperoxidation,
variations of glutathione, changes in cell structure, and cell
death 3,4,5,6. These alterations are the consequence of a
complex interaction between ATP consumption, intracellular
ion influx, microvascular disorders, release of inflammatory
mediators and oxygen-derived free radicals, as well as
activation of neutrophils, platelets, Kupffer cells and
endothelial cells, which induces the release of proteases
and phospholipases that potentially damage the cellular
and mitochondrial membranes1,2,3,4. The liver is an organ
that plays a central role in energy metabolism, especially
glucose metabolism. Normal glucose consumption by
hepatocytes is accompanied by phosphorylation to glucose
6-phosphate which may follow various metabolic routes
depending on supply and demand. Glucose 6-phosphate
preferentially maintains sufficient blood glucose levels to
supply energy to the brain and other tissues, and the
glucose that is not immediately utilized is stored as hepatic
glycogen. During the process of ischemia/reperfusion,
changes occur in these metabolic pathways and the
modified energy metabolism may worsen the pre-existing
hepatic dysfunction3,4,5,6,7,8. Previous studies from our
laboratory have shown a change in the metabolic pattern of
the liver from the glycogenetic to glycolytic way due to a
functional ischemic process during extrahepatic biliary
obstruction (A). Pyruvate kinase (PK) is a key enzyme that
coordinates gluconeogenesis and glycolysis since its
inhibition is essential to permit the activation of the
gluconeogenesis pathway. Thus, the objective of the present
study was to investigate the changes caused by hepatic
ischemia and reperfusion in energy metabolism (PK activity,
blood glucose concentration and hepatic glycogen content)
and the occurrence of lipoperoxidation (GSH and MDA
content) and their correlation with changes in hepatic
function, as well as the applicability of these parameters to
the ischemia and reperfusion syndrome.
Methods
The study was conducted in the Laboratory of Surgical
Hepatology and Experimental Surgery, Faculty of Medicine
of Ribeirão Preto and the Laboratory of Liver Unit
Transplantation - Unicamp. Twenty-four male Wistar rats
weighing 270 to 320 g were anesthetized with sodium
pentobarbital (50 mg/kg) through the caudal vein after a 12
hour fast but with water “ad libitum”. The abdomen was
shaved and the right carotid artery was dissected and
cannulated with a P50 catheter for blood collection for the
measurement of electrolytes and glycemia and for the
determination of mean arterial pressure with a Siemens
instrument. Median laparotomy was performed and the
lateral and middle left liver lobes were exposed. Selective
clamping of the portal triad of these lobes was performed
for 90 minutes in 12 rats (group A). While 12 other rats were
submitted to a sham operation (group B). Fifteen minutes
after releasing the clamp occluding the left portal triad
(reperfusion), blood was collected by puncturing the inferior
vena cava for measurement of alanine aminotransferase
(ALT). Mean arterial pressure was measured and the lateral
and left median lobes were collected for biochemical tissue
determinations.
• Biochemical analyses - Serum ALT was determined
by a kinetic method optimized by the Labtest Sistemas
Diagnósticos Ltda. Laboratory, and is reported as U/L.
Glycemia was determined by a kinetic method using glucose
oxidase and peroxidase and is reported as mg%.
• Hepatic tissue analyses - For the mitochondrial
preparation, the liver lobes were immediately placed in a
vessel containing ice-cold physiological saline (0 to 4 C),
cut into small fragments and transferred to another vessel
containing ice-cold physiological saline for the removal of
clots and blood from the fragments. The fragments were
then placed in homogenization medium containing 0.25 M
sucrose, 1 mM EDTA and 1 mg/ml albumin, pH 7.4. The
material was homogenized in a Potter-Elvehjem blender for
three cycles of about three seconds each, with a 1 minute
interval between cycles. The mitochondrial fraction was
isolated from the homogenate by the Pedersen differential
centrifugation technique. The homogenate obtained was
centrifuged with a refrigerated Hitachi Himac Cr 21
centrifuge (Japan) at 1080g for 5 minutes and the resulting
supernatant was centrifuged at 7690g for 10 minutes. The
supernatant of this centrifugation was stored in 0.3%
glycerol for the determination of PK activity and the
sediment was resuspended to the original volume in isolation
medium (0.25 M sucrose and 1 mM EDTA, pH 7.4) using an
“ice finger” and again centrifuged at 9000g for 10 minutes.
The final suspension (mitochondrial fraction) was then
frozen at -70o C for the determination of lipoperoxidation.
The tubes were placed in crushed ice throughout the
procedures, with the temperature kept at 0 to 4ºC.
• Determinationof hepatic glycogen - The glycogen
content was determined in frozen specimens of livers
isolated from rats.9
• Evaluation of mitochondrial lipoperoxidation -
Mitochondrial fraction samples frozen at -70 C were sent to
the Analytical Laboratory of the Discipline of Toxicology,
Faculty of Pharmaceutical Sciences of Ribeirão Preto,
University of São Paulo, for the determination of indicators
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of mitochondiral lipoperoxidation (hepatic mitochondrial
GSH and MDA).
• Determination of Hepatic MDA content: The
mitochondiral fraction was diluted with 1.15% KCl in order
to obtain a protein concentration of 10 mg/ml suspension
and 0.2 ml 8.1% sodium dodecyl sulfate, 1.5 ml 20% acetic
acid, pH 3.5, and 0.1 ml of a 0.8% thiobarbituric acid solution
were added to this suspension, plus water to a final volume
of 4.0 ml. The mixture was then heated at 95 C for 60 minutes,
the vessel containing the solution was cooled with running
water and 1 ml distilled water plus 5 ml n-butanol were added.
The test tube containing the solution thus obtained was
placed in a Phoenix shaker for 20 minutes and then
centrifuged at 3500 g for 10 minutes. The absorbance of the
organic phase was determined at 532 nm. MDA
concentration was calculated from a calibration curve
obtained to the procedure described above. The unit of
MDA concentration is reported as nmol/mg protein.
• Determination of hepatic GSH content - A 1.9 ml
aliquot of 1.15% KCl was added to 0.1 ml of the mitochondrial
fraction so as to obtain 2 mg protein/ml after which 0.2 ml
trichloroacetic acid (1g/ml) was added and then the mixture
was shaken and centrifuged at 35000 g for 10 minutes. Two
ml of the buffer solution (400 mM Tris-HCl and 20 mM
EDTA, pH 8.9) plus 0.1 ml 10 mM dinitrobenzene in methanol
were added and the mixture was shaken. Absorbance was
determined at 412 nm after 5 minutes. The unit of the GSH
concentration obtained is reported as nmol/mg protein.
• Evaluation of pyruvate kinase activation - PK
activity was determined by the spectrophotometric
method10. The supernatant of the second centrifugation (1
mg protein/ml) was added to a reaction medium containing
0.1 M Tris-HCl, pH 7.4, 4 mM KCl, 0.15 mM MgCl2, 5 µM
NADH, lactate dehydrogenase, 2 mM ADP, and 0.05 mM
phosphoenolpyruvate at a final volume of 1.0 ml and the
basal activity of the enzyme was measured. Fructose 1,6-
diphosphate (20 mM FDP) was then added and the enzyme
activation was determined. Under these conditions, 1 unit
of the enzyme catalyzed the formation of 1 ml pyruvate per
minute.10
• Statitical analysis - Data were analyzed statistically
by the Student t-test for independent samples, with the
level of significance set at p<0.05.
Results
Mean arterial pressure was 85 mmHg for group A
(ischemia and reperfusion); a lower value than 103 mmHg
was obtained for group B (sham operation). Mean ALT
concentration was 1013 IU/l for group A and 37 U/l for group
B. Mean glycemia was significantly higher in the ischemic
group being 262 mg% while in the sham-operated group it
was 120 mg% (Figure 1). Piruvate kinase activity was
significantly higher in group A, 1.82 x 10-2 nmol/ mg protein,
than in group B with 0.66 x 10-2 nmol/ mg protein (Figure 3).
The mean hepatic glycogen levels were lower in group A
than in group B, as shown in Figure 4.
FIGURE 1 - Graphic presentation of the determination of
glycemia (mg%) in the animals of group A (90
minutes of ischemia and 15 minutes of
reperfusion) and group B (sham operation).
The comparison showed a significant
difference (p<0.05).
FIGURE 2 - Graphic presentation of the determination of
hepatic mitochondrial glutathione (GSH in
nmol/ mg protein) in the animals of group A
(90 minutes of ischemia and 15 minutes of
reperfusion) and group B (sham operation).
The comparison showed a significant
difference (p<0.05).
FIGURE 3 - Graphic presentation of the determination of
hepatic tissue pyruvate kinase activity (PKA)
in the animals of group A (90 minutes of
ischemia and 15 minutes of reperfusion) and
group B (sham operation). The comparison
showed a significant difference (p<0.05).
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Discussion
The phenomena that occur after selective hepatic
ischemia are enhanced by reperfusion, although this is
theoretically the treatment for the lack of tissue oxygen1,2.
The lack of blood supply to hepatic tissue causes the
endothelial release of inflammatory mediators such as
interleukins, cyclooxygenases, arachidonic acid metabolites,
phospholipids, tumor necrosis factor, platelet activating
factor, ICAM-1, and selectin. These factors alter the
physiology of the microcirculation, leading to a fall in arterial
pressure mainly observed after reperfusion11,12. In the present
study there was a statistically significant fall in mean arterial
pressure in group A (ischemic) compared to group B (sham
operation). These results were expected but this
determination was performed so that we could establish
and verify the differences detected when analyzing the
biochemistry of hepatic tissue. The activation of Kupffer
cells and neutrophils caused by ischemia and reperfusion
themselves may be mediated by the platelet activating factor,
favoring the release of oxygen-derived free radicals and
increased calcium influx especially after reperfusion, and
reduction of the antioxidant agents superoxide dismutase,
catalase and GSH6,7,8,11,12, leading to a reduction in NADPH
and limiting the peroxide reduction by the antioxidant GSH
system and increasing MDA production. Phospholipase
activation may cause severe damage to the membrane lipids,
changes in mitochondrial permeability and in DNA, proteins,
lipids and other macromolecules and oxidative stress
progressed during ischemia and triggered the oxidative injury
after reperfusion6,7,8,10,12,13. Alanine and aspartate
aminotransferases (ALT and AST), when present at high
concentrations, indicate hepatocellular injury and changes
in cytoplasmic membrane permeability. The ischemic group
presented mean ALT levels of 1013 IU/l after 15 minutes of
reperfusion, showing that, indeed, there was acute
hepatocyte injury caused by ischemia.13 This hepatic injury
was also observed in terms of glycemia which presented
mean levels of 262%, indicating that there was glycogen
mobilization, with reduced mean glycogen levels in the
FIGURE 4 - Graphic presentation of hepatic glycogen
tissue level determined in animals of
group A (90 minutes of ischemia and 15
minutes of reperfusion) and group B
(sham operation). The comparison showed
a significant difference (p<0.05).
ischemic group, and increased basal pyruvate kinase
activity. This activity was increased due to the ichemia/
reperfusion process and occurred through the glycolytic
pathway. Inomoto et al5 observed that the glycolytic
process is increased in both cold and warm ischemia, with a
balance between glycolysis and gluconeogenesis and a
reduction in phosphofructokinase only in warm ischemia.
This study of the glycolytic pathway may be important to
determine the most important time of injury during
preservation and reperfusion. Saiki et al. suggested that
phosphoenolpyruvate recovers hepatic energy from liver
cell damage by prompt ATP production through the
degradation into pyruvate in the liver by pyruvate kinase14.
Probably be the pyruvate kinase decrease founded in our
ischemic group. Lipoperoxidation of biological membranes
is a destructive process started by oxygen-derived free
radicals5,6,7 causing edema and increased calcium influx with
consequent mitochondrial dysfunction due to the fact that,
once the ischemia/reperfusion condition is initiated, H2O2
and OH free radicals can open channels in the mitochondrial
membrane by attacking the sulfhydryl groups of certain
proteins exposed by Ca++ binding; the increase of this ion
may activate mitochondrial phospholipase A2 inducing
increased OHº formation. The lipoperoxides formed can be
reduced by GSH and allopurinol, vitamin E and alpha-
tocopherol6. Reduced GSH is a cellular antioxidant
metabolized in the cell by glutathione peroxidase which
catalyzes the conversion of oxygen peroxide to oxygen and
water. This system of reduction by GSH is one of the
processes used by the mitochondria to remain stable. During
ischemic and reperfusion processes there is a loss of the
mitochondiral antioxidant ability and the cells become more
sensitive to the effects of excessive production of oxygen-
derived free radicals, and these changes are detected by
the appearance of lipoperoxidation products such as MDA
and the decrease in hepatic mitochondrial GSH
content6,7,8,9,11,12,13,14. The occurrence of lipid peroxidation is
measured by the increase in hepatic mitochondrial MDA
and by the decrease in hepatic mitochondrial GSH that
occurs after liver reperfusion14. In the present study the
ischemic group (A) presented higher mean MDA levels than
group B and lower mean GSH levels than group B. These
results demonstrate that lipid peroxidation occurred during
the process of hepatic tissue reperfusion. Changes in mean
arterial pressure, acute hepatocyte injury, lipid peroxidation,
and increased basal pyruvate kinase activity occurred after
selective hepatic ischemia and 15 minutes reperfusion and
that this activation mainly occurred through the glycolytic
pathway.
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